Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer

BACKGROUND: Chemotherapy for pancreatic carcinoma often has severe side effects that limit its efficacy. The glucocorticoid (GC) dexamethasone (DEX) is frequently used as co-treatment to prevent side effects of chemotherapy such as nausea, for palliative purposes and to treat allergic reactions. Whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chengwen, Kolb, Armin, Büchler, Peter, Cato, Andrew CB, Mattern, Jürgen, Rittgen, Werner, Edler, Lutz, Debatin, Klaus-Michael, Büchler, Markus W, Friess, Helmut, Herr, Ingrid
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434760/
https://www.ncbi.nlm.nih.gov/pubmed/16539710
http://dx.doi.org/10.1186/1471-2407-6-61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434760/
https://www.ncbi.nlm.nih.gov/pubmed/16539710
http://dx.doi.org/10.1186/1471-2407-6-61

Ejemplares similares